PTGX
Protagonist Therapeutics, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $552M | +10.0% |
| Gross profit | $273MQ3 2026 | — |
| Operating income | $323M | — |
| Net income | $342M | — |
| EPS | $4.72 | — |
| Free cash flow | $109M | — |
Protagonist Therapeutics, Inc.
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $552M | +10.0% |
| Gross profit | $273MQ3 2026 | — |
| Operating income | $323M | — |
| Net income | $342M | — |
| EPS | $4.72 | — |
| Free cash flow | $109M | — |